Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Expression of Wiskott-Aldrich syndrome protein in dendritic cells regulates synapse formation and activation of naive CD8+ T cellsJulian Pulecio, Elisa Tagliani, Alix Scholer, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 2, 2020
Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in ratsYannick Fotio, Anna Maria Borruto, Federica Benvenuti, et al.Human Vaccines & Immunotherapeutics|November 27, 2014
Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccineMayrel Labrada, Isabel Pablos, Francesca Prete, et al.Cells|April 30, 2021
Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I InterferonsAlessandra Tesser, Giulia Maria Piperno, Alessia Pin, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytesFederica Benvenuti, Cecile Lagaudrière-Gesbert, Isabelle Grandjean, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2023
Traumatic Stress-Induced Increases in Anxiety-like Behavior and Alcohol Self-Administration Are Mediated by Central Amygdala CRF1 Neurons That Project to the Lateral HypothalamusMarcus M Weera, Daniel A Webster, Rosetta S Shackett, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cellsElisa Tagliani, Pierre Guermonprez, Jorge Sepúlveda, et al.Science (New York, N.Y.)|August 25, 2004
Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell primingFederica Benvenuti, Stephanie Hugues, Marita Walmsley, et al.Neuropharmacology|June 20, 2024
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacyNazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.Biorxiv : the Preprint Server for Biology|August 7, 2023
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacyVeronica Lunerti, Qianwei Shen, Hongwu Li, et al.Pageof 6